OncoArendi Therapeutics

    OverviewSuggest Edit

    OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates. It studies the therapeutic potential of chitinases and chitinase-like-proteins (CLPs) in diverse inflammatory and fibrotic diseases. The company develops OATD-01 (a therapy for multiple lung diseases), YKL-40 (a glioblastoma multiforme therapy for cancers), and more.
    TypePrivate
    Founded2012
    HQWarszawa, PL
    Websiteoncoarendi.com

    Locations

    OncoArendi Therapeutics is headquartered in
    Warszawa, Poland

    Location Map

    Latest Updates

    Employees (est.) (Jul 2021)52(-3%)
    Cybersecurity ratingAMore

    Key People/Management at OncoArendi Therapeutics

    Marcin Szumowski

    Marcin Szumowski

    President of the Board, Chief Executive Officer
    Krzysztof Laskowski

    Krzysztof Laskowski

    Chairman of the Supervisory Board
    Sławomir Broniarek

    Sławomir Broniarek

    Member of the Board, Chief Financial Officer
    Rafał Kamiński

    Rafał Kamiński

    Member of the Board, Chief Scientific Officer
    Nicolas Beuzen

    Nicolas Beuzen

    Business Development Director
    Robert Dyjas

    Robert Dyjas

    Medical Director
    Show more

    OncoArendi Therapeutics Office Locations

    OncoArendi Therapeutics has an office in Warszawa
    Warszawa, PL (HQ)
    Marszałkowska 82
    Show all (1)

    OncoArendi Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2012

    OncoArendi Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    95/100

    SecurityScorecard logo

    OncoArendi Therapeutics Online and Social Media Presence

    Embed Graph

    OncoArendi Therapeutics Frequently Asked Questions

    • When was OncoArendi Therapeutics founded?

      OncoArendi Therapeutics was founded in 2012.

    • Who are OncoArendi Therapeutics key executives?

      OncoArendi Therapeutics's key executives are Marcin Szumowski, Krzysztof Laskowski and Sławomir Broniarek.

    • How many employees does OncoArendi Therapeutics have?

      OncoArendi Therapeutics has 52 employees.

    • Who are OncoArendi Therapeutics competitors?

      Competitors of OncoArendi Therapeutics include Oncology Pharma, Oscotec and Luye Pharma.

    • Where is OncoArendi Therapeutics headquarters?

      OncoArendi Therapeutics headquarters is located at Marszałkowska 82, Warszawa.

    • Where are OncoArendi Therapeutics offices?

      OncoArendi Therapeutics has an office in Warszawa.

    • How many offices does OncoArendi Therapeutics have?

      OncoArendi Therapeutics has 1 office.